Sort   by:  
 Page size 
UnknownAstroglial expression of human alpha(1)-antichymotrypsin enhances alzheimer-like pathology in amyloid protein precursor transgenic mice.
Not available
S-EPMC1885780 | biostudies-literature
UnknownHsp70 chaperone blocks α-synuclein oligomer formation via a novel engagement mechanism.
Not available
S-EPMC8102405 | biostudies-literature
UnknownPlaque-independent disruption of neural circuits in Alzheimer's disease mouse models.
Not available
S-EPMC15924 | biostudies-literature
UnknownHigh-level neuronal expression of abeta 1-42 in wild-type human amyloid protein precursor transgenic mice: synaptotoxicity without plaque formation.
Not available
S-EPMC6772621 | biostudies-literature
UnknownIdentification of Small Molecule Inhibitors of Tau Aggregation by Targeting Monomeric Tau As a Potential Therapeutic Approach for Tauopathies.
Not available
S-EPMC4976804 | biostudies-literature
UnknownPassive immunization reduces behavioral and neuropathological deficits in an alpha-synuclein transgenic model of Lewy body disease.
Not available
S-EPMC3084838 | biostudies-literature
UnknownElevated alpha-synuclein impairs innate immune cell function and provides a potential peripheral biomarker for Parkinson's disease.
Not available
S-EPMC3751933 | biostudies-literature
UnknownTargeting the intrinsically disordered structural ensemble of α-synuclein by small molecules as a potential therapeutic strategy for Parkinson's disease.
Not available
S-EPMC3925190 | biostudies-literature
UnknownPolo-like kinase 2 (PLK2) phosphorylates alpha-synuclein at serine 129 in central nervous system.
Not available
S-EPMC2631975 | biostudies-literature
UnknownNovel Small Molecules Targeting the Intrinsically Disordered Structural Ensemble of α-Synuclein Protect Against Diverse α-Synuclein Mediated Dysfunctions.
Not available
S-EPMC6861283 | biostudies-literature
Sort   by:  
 Page size